Related Experiment Video
Updated: Jul 17, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Neurological outcomes and disability predictors in paediatric herpes simplex virus encephalitis: a multicentre cohort
Caroline Rey1, Laetitia Giorgi2, Hélène Maurey2
1Pediatric Neurology Department, Assistance Publique-Hôpitaux de Paris, Paris-Saclay University Hospitals, Bicêtre Hospital, Faculty of Medecine, Paris-Saclay University, Le Kremlin-Bicêtre, France.
Insights
Neurological disabilities remain high in children with Herpes Simplex Virus Encephalitis (HSVE), despite reduced mortality. Identifying risk factors like age and seizure onset can guide early interventions and improve outcomes for pediatric HSVE patients.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroscience
Background:
- Herpes Simplex Virus Encephalitis (HSVE) is a severe neurological infection in children.
- Long-term neurological deficits are common sequelae in survivors.
- Effective management strategies require understanding factors influencing neurological outcomes.
Purpose of the Study:
- To identify clinical and paraclinical factors associated with neurological outcomes in children diagnosed with HSVE.
- To analyze the relationship between early disease indicators and long-term neurological sequelae.
Main Methods:
- Retrospective, multicentric observational study.
- Inclusion of children aged 28 days to 18 years with HSVE.
- Statistical analyses (univariate and multivariate) of clinical data, onset characteristics, and neurological outcomes.
Main Results:
- 76% of 49 children experienced poor neurological outcomes, including epilepsy (57%), intellectual disability (51%), and language disorders (47%).
- Younger age, seizures at onset, and abnormal MRI findings were associated with adverse neurological outcomes.
- Epilepsy linked to female sex and insular lesions; language disorders to seizures; motor disorders to younger age and thalamic lesions.
Conclusions:
- Neurological disabilities persist at high rates in pediatric HSVE survivors.
- Early identification of risk factors (e.g., younger age, seizures, specific lesion locations) is crucial.
- Enhanced management strategies, including potential immunotherapy and intensive rehabilitation, are needed for high-risk children.
Objective:
To identify factors associated with the neurological outcome of HSVE in children.
Materials And Methods:
In this retrospective multicentric observational study, clinical, paraclinical data at onset and neurological outcomes at last follow-up of children (≥28 days and <18 years old) with HSVE, were studied. Univariate and multivariate analyses were performed to identify factors associated with neurological outcome.
Results:
49 children (mean age of 4.9 ± 5.5 years) were included. At last follow-up of 5.9 ± 3,13 years, 2 children died (4 %) and 37 (76 %) children presented with poor neurological outcome with epilepsy (57 %), intellectual disability (51 %) and language disorders (47 %). Rehabilitation was necessary for 76 % and 59 % had abnormal academic performances. At onset, younger age and seizures were significantly associated to language disorders (p < 0.01), motor disabilities (p = 0.01), and intellectual disabilities (p = 0.01) in univariate analysis. Abnormal MRIs were more frequent in children with neurological sequalae (p = 0.01). Multivariate analyses identified that: (1) epilepsy occurred more frequently in females (p = 0.03), with insular lesions (p = 0.048); (2) language disorders were more common in children who had seizures at onset (p 0.02); (3) motor disorders were more frequent in younger children (p = 0.03) with thalamic lesions (p = 0.04).
Conclusion:
Our findings indicate that despite decrease in mortality rates, neurological disabilities in children with HSVE still persist at high levels. This underscores the need to enhance HSVE management strategies. Moreover, the identified risk factors associated with poor neurological outcomes can aid in identifying high-risk children, facilitating the implementation of alternative treatment approaches such as immunotherapy or intensive rehabilitation.
Related Concept Videos
Herpes
Arboviral Encephalitis
Genital Herpes
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

